Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Roche enlists Alector in Parkinson's deal, paying $100M upfront

Alector is teaming up with another large drugmaker, fresh off a separate partnership collapsing. Alector will get $100 million upfront from Roche in a deal centered on the biotech’s neuroscience and Parkinson’s disease efforts. If ...

We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.

Read the original at endpoints.news →

More in Health & Medicine

More from Monday 5 October →